Appendix 3C - Notification of buy-backAppendix 3C - Notification of buy-back1 / 6Announcement SummaryName of entityCSL LIMITEDAnnouncement typeUpdate announcementType of updateDate of this announcement16/9/2026Reason for updateDaily buy-back notificationASX Security code and description of the...
Update - Notification of buy-back - CSL
Filed with ASX · · 6 pages · English
Release
Earlier from CSL
- Update - Dividend/Distribution - CSL
- Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults
- Application for quotation of securities - CSL
- Notification regarding unquoted securities - CSL
- Notification of cessation of securities - CSL
Later from CSL
- Notice of Meeting and Shareholder Pack 2026
- Public Access to ANDEMBRY® (garadacimab) Expands Across Canada for the Prevention of Hereditary Angioedema (HAE) Attacks
- UK Government Strengthens Vaccine Partnership with CSL Seqirus, Introducing World-First Flu vaccine (aTIVc) and Extending Health Security Pandemic Agreement
- CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
- CSL enters exclusive agreement with Alentis Therapeutics
Follow CSL into a list and get an email when it puts out news.
Follow CSL